Wave Life Sciences Ltd. (WVE) Profit Margins
Over the twelve months to 2026-06-30, Wave Life Sciences Ltd. (WVE) had operating margin -333.4%, net margin -309.7%, free cash flow margin -295.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WVEWave Life Sciences Ltd.Follow WVE — free
—
Price chart with a free account
- Market cap
- 626.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -12696.1% | -3752.2% | -2764.3% | -1106.7% | -1303.4% | -763.9% | -310.1% | -4459.3% | -60.0% | -101.9% | -504.1% | -333.4% | |
| Net margin | -12631.6% | -3748.1% | -2753.2% | -1017.4% | -1211.5% | -746.7% | -298.4% | -4434.7% | -50.8% | -89.6% | -478.3% | -309.7% | |
| FCF margin | -9463.2% | -2521.1% | -2768.8% | -227.6% | -1202.2% | -584.4% | -218.6% | -3539.1% | -18.1% | -140.3% | -440.5% | -295.5% |
USD millions · SEC XBRL
Wave Life Sciences Ltd. — questions
- What is Wave Life Sciences Ltd.'s operating margin?
- -333.4% over the twelve months to 2026-06-30.
- What is Wave Life Sciences Ltd.'s net profit margin?
- -309.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Wave Life Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.